Morgan Stanley Cuts Zimmer Biomet (NYSE:ZBH) Price Target to $95.00
Zimmer Biomet (NYSE:ZBH – Free Report) had its target price decreased by Morgan Stanley from $115.00 to $95.00 in a research report released on Tuesday morning,Benzinga reports. Morgan Stanley currently has an equal weight rating on the medical equipment provider’s stock. Several other research firms have also weighed in on ZBH. Needham & Company LLC […]
Zimmer Biomet (NYSE:ZBH – Free Report) had its target price decreased by Morgan Stanley from $115.00 to $95.00 in a research report released on Tuesday morning,Benzinga reports. Morgan Stanley currently has an equal weight rating on the medical equipment provider’s stock. Several other research firms have also weighed in on ZBH. Needham & Company LLC […]
